Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingzhao Xing

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 5, 2009
Identifying genetic alterations in poorly differentiated thyroid cancer: a rewarding pursuitMingzhao Xing
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Reply to C. Bal et alMingzhao Xing
Otolaryngologic Clinics of North America|December 2, 2008
Recent advances in molecular biology of thyroid cancer and their clinical implicationsMingzhao Xing
JAMA|August 9, 2013
BRAF V600E mutation and papillary thyroid cancer--in replyMingzhao Xing
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
BRAFV600E mutation and papillary thyroid cancer: chicken or egg?Mingzhao Xing
Cell Cycle (Georgetown, Tex.)|April 28, 2010
Pituitary homeobox 2 in thyroid tumorigenesis: extension from its classical developmental roleMingzhao Xing
The Lancet. Oncology|December 25, 2025
Tumour genetics and thyroid cancer stagingMingzhao Xing
Clinical Endocrinology|August 25, 2005
The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancerMingzhao Xing
Nature Reviews. Cancer|February 23, 2013
Molecular pathogenesis and mechanisms of thyroid cancerMingzhao Xing
Endocrine Journal|December 3, 2008
[Comments on the Ito et al. article (Endocr J. 2008 Oct 8. Epub ahead of print)] The lack of clinicopathological correlation of BRAF mutation in papillary thyroid cancer needs to be interpreted with cautionMingzhao Xing
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|December 5, 2009
Identifying genetic alterations in poorly differentiated thyroid cancer: a rewarding pursuitMingzhao Xing
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Reply to C. Bal et alMingzhao Xing
Otolaryngologic Clinics of North America|December 2, 2008
Recent advances in molecular biology of thyroid cancer and their clinical implicationsMingzhao Xing
JAMA|August 9, 2013
BRAF V600E mutation and papillary thyroid cancer--in replyMingzhao Xing
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
BRAFV600E mutation and papillary thyroid cancer: chicken or egg?Mingzhao Xing
Cell Cycle (Georgetown, Tex.)|April 28, 2010
Pituitary homeobox 2 in thyroid tumorigenesis: extension from its classical developmental roleMingzhao Xing
The Lancet. Oncology|December 25, 2025
Tumour genetics and thyroid cancer stagingMingzhao Xing
Clinical Endocrinology|August 25, 2005
The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancerMingzhao Xing
Nature Reviews. Cancer|February 23, 2013
Molecular pathogenesis and mechanisms of thyroid cancerMingzhao Xing
Endocrine Journal|December 3, 2008
[Comments on the Ito et al. article (Endocr J. 2008 Oct 8. Epub ahead of print)] The lack of clinicopathological correlation of BRAF mutation in papillary thyroid cancer needs to be interpreted with cautionMingzhao Xing
Pageof 16